Phase change materials (PCMs) allow the storage of large amounts of latent heat during
phase transition. They have the potential to both increase the efficiency of renewable …

Due to lack of specification and solubility of drug molecules, patients have to take high
doses of the drug to achieve the desired therapeutic effects for the treatment of diseases. To …

This review provides a perspective on porous silicon (pSi)–based nanomaterials including
nanoparticles, nanowires, and thin films, that are currently being used in advanced therapy …

The research on porous silicon (PSi) materials for biomedical applications has expanded
greatly since the early studies of Leigh Canham more than 25 years ago. Currently, PSi …

Nanomaterials provide a unique platform for the development of theranostic systems that
combine diagnostic imaging modalities with a therapeutic payload in a single probe. In this …

Ischemic heart disease is the leading cause of death globally. Severe myocardial ischemia
results in a massive loss of myocytes and acute myocardial infarction, the endocardium …

Platinum-based anticancer drugs currently available in the market are associated with
severe side effects. Therefore, extensive research has been performed to design and …

Hydrophilic layers of porous silicon are prepared by single‐or two‐step anodization and
characterized by evaluating their surface hydrophilicity and contents of functional groups …

Introduction: Porous silicon (pSi) engineered by electrochemical etching has been used as a
drug delivery vehicle to address the intrinsic limitations of traditional therapeutics …

Chronic heart failure, predominantly developed after myocardial infarction, is a leading
cause of high mortality worldwide. As existing therapies have still limited success, natural …